Asia Pacific NIPAH virus
diagnostics market is projected to boom in the upcoming five years while
exhibiting an impressive CAGR. In the last five years from 2018 to 2022, the
market has experienced quite a growth that was counted in millions of sales and
is anticipated to project its growth in the forecast period, 2024-2028 on the
account of increasing demand for early diagnostics of the NIPAH virus.
NIPAH virus is a strain of
zoonotic virus that spreads among animals and humans likewise. The virus has
the tendency to transmit from animals to humans. The outbreak of COVID-19 virus
is the most recent and major example of NIPAH virus effect on the human life.
The virus is also known to cause illness in pigs and people. It is associated
with the disease called encephalitis that is swelling of the brain. The adverse
effect of this virus may cause death. During an outbreak, standard infection
control practices can help prevent person-to-person spread in hospital
settings.
Some of the major players in the
Asia Pacific NIPAH virus diagnostics market include Abbott Laboratories, Roche
Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, and Qiagen N.V.
These companies are investing heavily in research and development activities to
develop new and advanced diagnostic tools for NIPAH virus detection.
Additionally, the Asia Pacific NIPAH virus diagnostics market is also
characterized by the presence of local players who cater to the specific needs
of the region. For instance, Indian companies such as J Mitra & Co. and
BioMerieux India are offering cost-effective diagnostic solutions to the local
market. In addition to diagnostics, the Asia Pacific region is also witnessing
an increase in the development of therapeutics and vaccines for NIPAH virus.
Several pharmaceutical companies are working on the development of vaccines and
antiviral drugs to combat the virus.
Moreover, the growing number of
government initiatives aimed at controlling the spread of NIPAH virus is also
contributing to the growth of NIPAH Virus Diagnostics market in the Asia
Pacific region. For example, the Indian government has launched several
awareness campaigns and implemented strict control measures to prevent the
spread of the virus. These efforts are driving demand for diagnostic tests which
in turn rises the growth of Asia Pacific NIPAH Virus Diagnostic Market.
COVID-19 Surged Demand for NIPAH
Virus Diagnostics
Recent conditions of the
pandemic surged the demand for the diagnosis and identification of adverse
effects of the virus among bats and then in the human population. The outbreak
of coronavirus although was not related to COVID-19 but the NIPAH virus
upsurged due to the outbreak. In countries like India and China, etc. the virus
added to the infection and death counts that increased during the pandemic.
Demand for the early diagnostic and effective and efficient testing along with
the treatment aided the growth of the Asia Pacific NIPAH virus diagnostics
market in the upcoming five years. Government authorities further stepped-up
contact tracing efforts, identifying, quarantining, and testing people who may
have meet the victims, thereby supporting the growth of the Asia Pacific NIPAH
virus diagnostics market in the future five years.
Increasing incidence of NIPAH
virus cases
The Asia Pacific region has seen
a significant increase in the number of NIPAH virus cases in recent years.
According to the World Health Organization (WHO), between 2001 and 2018, there
were 596 reported cases of NIPAH virus in the region, with a case fatality rate
of approximately 40%. This has led to an increased demand for accurate and
efficient diagnostics tools for early detection and treatment of the
disease.With the increasing incidence of NIPAH virus cases, there is also a
growing awareness of the disease among healthcare professionals and the general
public. This has led to an increased demand for diagnostics tools and has also
prompted governments to invest in healthcare infrastructure and research and
development activities to combat the disease.
Increasing Number of Testing
Kits Support Market Growth
Research institutes and market
players are actively involved in introducing effective testing kits for the
identification of the NIPAH virus infections. The surge in the demand for the
early diagnostics is driving the demand for the innovative and effective
testing kits such that market is also expected to aid the growth of the Asia
Pacific NIPAH virus diagnostics market in the next five years. Increasing
incidences of the diseases caused by the NIPAH virus is further aiding the
growth of the Asia Pacific NIPAH virus diagnostics market in the upcoming five
years. Increased commercialization of the testing kit is also supporting the
growth of the Asia Pacific NIPAH virus diagnostics market in the future five
years.
Technological Advancements Aid
Market Growth
Since the outbreak of NIPAH
virus is very sudden, consistent research and technological advancement towards
formulating better diagnostic kits and treatment procedure is a must. Due to
sudden outbreaks, there is sudden increase in demand for diagnostic kits. Early
diagnostics and then the treatment for the virulent infection creates demand
for the technologically advanced NIPAH virus testing kits, thereby supporting
the growth of the Asia Pacific NIPAH virus diagnostics market in the next five
years.
The NIPAH virus belongs to the
class of Paramyxoviridae viruses. The World Health Organization (WHO) has put
forth a 5-year framework for identifying the virus strains and formulate
strategies to create a set up where earliest diagnostic kits can be organized.
These steps are taken for the consideration towards reducing death and
morbidity rates that starts to rise with the immediate spread of NiV virus. The
development of new and advanced diagnostic technologies is also driving growth
in the Asia Pacific NIPAH virus diagnostics market. Rapid diagnostic tests,
which can provide results in minutes, are becoming increasingly popular, as
they allow for quick and easy diagnosis of NIPAH virus infections in the field.
Additionally, advances in molecular diagnostic techniques, such as PCR
(polymerase chain reaction), are improving the accuracy and sensitivity of
NIPAH virus detection and leads to the development of Asia Pacific NIPAH Virus
Diagnostic Market.
Lack of awareness and knowledge
regarding NIPAH Virus
One of the major restraining
factors for the Asia Pacific NIPAH virus diagnostics market is the lack of
awareness and knowledge about NIPAH virus infection. Many people in the region
are still unaware of the disease, its symptoms, and the potential risks
associated with it. This lack of knowledge and awareness leads to a delay in
seeking medical attention, which can worsen the condition of the patient and
increase the risk of transmission. Therefore, it will give rise to the growth
of Asia Pacific NIPAH Virus Diagnostic Market.
Download Free Sample Report
Market Segmentation
The Asia Pacific NIPAH virus
diagnostics market is segmented based on test type, sample, end user,
competitional landscape, and country analysis. Based on test type, the market
is further fragmented into RT PCR, and ELISA. Based on sample, the market is segmented
into throat & nasal swab, urine, blood, and others. Based on end user, the
market is further segmented into hospitals & clinics, diagnostics
laboratories, and others. The market analysis also studies the country analysis
segmentation to devise country-based share segmentation analyzing, China,
India, Japan, South Korea, Australia, Bangladesh, Myanmar, Singapore,
Philippines, and Thailand.
Company Profile
A partial list of major
shareholders of the Asia Pacific NIPAH virus diagnostics market includes,
Molbio Diagnostics Pvt. Ltd., Krishgen Biosystems, MyBioSource, Inc., Liferiver
Bio-Tech (United States) Corp, Roche Holding AG, Vivacure Limited, Siegfried
AG, Aurobindo Pharma, Minapharm Pharmaceuticals, Starlake Bioscience Co. The
market players are actively involved in the extended research related to
various equipment, services, and researching the market to substantiate the
growth of the Asia-Pacific NIPAH virus diagnostic market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 – 2022
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2024 – 2028
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
|
Report Coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments Covered
|
·
Test Type
·
Sample
·
End User
·
Region
·
Company
|
|
Country Scope
|
China, India, Japan, South Korea, Australia, Bangladesh,
Myanmar, Singapore, Philippines, and Thailand
|
|
Key Companies Profiled
|
Molbio Diagnostics Pvt. Ltd., Krishgen Biosystems,
MyBioSource, Inc., Liferiver Bio-Tech (United States) Corp, Roche Holding AG,
Vivacure Limited, Siegfried AG, Aurobindo Pharma, Minapharm Pharmaceuticals,
Starlake Bioscience Co.
|
|
Customization Scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
|
Pricing and Purchase Options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email
(We can also provide the editable version of the report in PPT/Word format on
special request)
|
Report Scope:
In this report, Asia Pacific
NIPAH virus diagnostics market has been segmented into following
categories, in addition to the industry trends which have also been detailed
below:
- Asia Pacific NIPAH Virus
Diagnostics Market, By Test Type:
- Asia Pacific NIPAH Virus
Diagnostics Market, By Sample:
o Throat
& Nasal Swab
o Urine
o Blood
o Others
- Asia Pacific NIPAH Virus
Diagnostics Market, By End User:
- Hospitals & Clinics
- Diagnostics Laboratories
- Others
- Asia Pacific NIPAH Virus
Diagnostics Market, By Country:
- China
- India
- Japan
- South Korea
- Australia
- Bangladesh
- Myanmar
- Singapore
- Philippines
- Thailand
Competitive Landscape
Company Profiles: Detailed
analysis of the major companies present in Asia Pacific NIPAH virus diagnostics
market.
Available Customizations:
With the given market data,
TechSci Research offers customizations according to a company’s specific needs.
The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
Asia Pacific NIPAH Virus
Diagnostics Market is an upcoming report to be released soon. If you wish an
early delivery of this report or want to confirm the date of release, please
contact us at [email protected]